Analyst Ratings for Pyxis Oncology Inc. (PYXS)
PYXS Rating Summary
PYXS Price Target Summary
- Highest: $19.00 (Wells Fargo)
- Lowest: $5.00 (RBC Capital)
- Average: $8.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.67 (+165%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$8.67 (+165%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/3/2026 | Wells Fargo » Updated 9/10/2026 |
Derek Archila | New Coverage | Overweight (N/A) |
19.00 (12.00) |
2.65 (3.27) |
23.4% | Details |
| 5/5/2026 | Wedbush » Updated 9/10/2026 |
Robert Driscoll | New Coverage | Outperform (N/A) |
8.00 (6.00) |
1.76 (3.27) |
85.8% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
